Tergynan treatment of bacterial vaginosis (BV) and urogenital candidosis (UGC)

The data about treatment of BV and UGC by local application combined preparation of tergynan are submitted in the article. Efficiency of application of tergynan was compared with approved methods of treatment given diseases with using of 2% dalacin-vaginal cream (n=30) and jenamasolum (n=13). Was established that treatment BV was ascertained at 82,8% and UGC at 63,3% patients. Relapces were marked in 3 months after the ending of treatment accordingly at 18,8% patients with BV and 18,7% patients with UGC. It is recommended to apply tergynan for treatment BV, UGC and to preventive maintenance of infectious complications after labor, abortions and vaginals operations.